GlaxoSmithKline PLC ADR (GSK NYSE) stock market data APIs
$39.9246
0.38(1%)
as of September 15, 2025
Try our APIs with
free plan!
GlaxoSmithKline PLC ADR Financial Data Overview
Price chart is built with
Anychart
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in London, United Kingdom.
Prev. Close
39.9246
Open
40.3063
High
40.7498
Low
39.857
52 wk Range
30.6792-42.1649
Market Cap
82 175 M
P/E Ratio
17.9911
Shares Outstanding
2 013 M
Revenue
31 631 M
EPS
1.24
Dividends (Yield)
0.0409
Beta
0.289
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with GlaxoSmithKline PLC ADR (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get GlaxoSmithKline PLC ADR data using free add-ons & libraries
Get GlaxoSmithKline PLC ADR Fundamental Data
GlaxoSmithKline PLC ADR Fundamental data includes:
- Net Revenue: 31 631 M
- EBITDA: 9 291 M
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-07-30
- EPS/Forecast: 1.11
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
GlaxoSmithKline PLC ADR News
New
Flu RNA Vaccines Market Report 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and Challenges
Dublin, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The "Flu RNA Vaccines Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and Chal...
Haleon downgraded at Barclays on US consumer slowdown; falls on LSE
[Some Robitussin Honey Cough Syrups Being Recalled Over Microbial Contamination] Justin Sullivan/Getty Images News Barclays downgraded Haleon (NYSE:HLN [https://seekingalpha.com/symbol/HLN]) to equal...
Five new members added to CDC vaccine advisory panel
[CDC Centers for Disease Control and Prevention] The U.S. Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC) have added five new members to the CDC...
Notable healthcare headlines for the week: Novo Nordisk, Novartis and UnitedHealth in focus
Wall Street's major averages closed mixed on Friday, with the Nasdaq Composite (COMP:IND [https://seekingalpha.com/symbol/COMP:IND]) closing at new highs every day of the week, while the Dow (DJI [htt...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
